Hence then, the article about cantex pharmaceuticals receives fda orphan drug designation for azeliragon for the treatment of brain metastasis from breast cancer was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( CANTEX PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR AZELIRAGON FOR THE TREATMENT OF BRAIN METASTASIS FROM BREAST CANCER )
Last updated :
Also on site :
- US cable outlines new ‘construct’ to control Strait of Hormuz – media
- Could the US-Iran war become a protracted ‘frozen’ conflict?
- Laufey Explains How ‘A Matter of Time’ Changed Her Life & “Madwoman” Music Video .. Billboard Women In Music 2026